Abstract: Disclosed are a game data verification method performed by an electronic device. The method includes: generating a target sequence of target nodes in response to a game start instruction; acquiring target game data corresponding to each of the target nodes, the target game data including game state data and encrypted state data; performing authenticity verification on the target game data of a current target node according to the encrypted state data of a previous target node and the game state data of the current target node; performing accuracy verification on the target game data of the current target node according to the game state data of the current target node and game logic; and after determining that all the target game data corresponding to the target sequence is authentic data and accurate data based on an authenticity verification result and an accuracy verification result, determining that the game verification succeeds.

Abstract: An object processing method includes: displaying a first operation interface in response to triggering a first operation control of a first stage of a target object, the first operation interface including at least one first operation item; displaying a content input interface in response to completing an operation for the at least one first operation item, the content input interface including at least one input item; in response to completion of content input for the at least one input item, determining a second target value and generating a second operation control corresponding to a second stage of the target object; displaying a second operation interface in response to triggering the second operation control, the second operation interface including at least one second operation item; and updating the state of the target object to a completed state in response to completing an operation for the second operation item.

Abstract: The compound as shown in formula (I) or a pharmaceutically acceptable salt or pharmaceutical composition thereof, and a preparation method therefor, and the use thereof as an MAT2A inhibitor. Ring A, ring Q, X, Y, X1, X2, L and R1 in formula (I) are as defined in the description.

Abstract: A genus of bicyclic inhibitors of CBX chromodomains is disclosed. The compounds are of the following genus: The compounds inhibit CBX proteins and, as a consequence, they are useful for treating prostate cancer, ovarian cancer, and B-cell lymphoma.